Ensign Group, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by The Ensign Group, Inc. on November 2, 2009, covering events occurring on October 29, 2009. The filing primarily serves to reference a press release issued on November 2, 2009, detailing financial results for the second quarter ended September 30, 2009.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the body of this 8-K document.
Material Changes
No material changes to financial condition or operations are described within the text of this filing. The document acts as a conduit to the separate press release containing the quarterly results.
Guidance, Outlook, and Other Events
- Conference Participation: On October 29, 2009, the Company announced its participation in the Oppenheimer & Co., Inc. 20th Annual Healthcare Conference scheduled for November 3-4, 2009, in New York City.
- Legal Disclaimer: The information furnished in this report, including the attached exhibits, is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any registration statement.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 2, 2009) for specific Q2 2009 financial figures and year-over-year comparisons.
- Verify the Company's presentation details at the Oppenheimer & Co. Healthcare Conference.
- Confirm that the financial data in the press release aligns with the Company's previously filed 10-Q for the period ended September 30, 2009.